Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PHIO | 8-K | neutral | 3/10 | Phio Pharmaceuticals announced the successful completion of its first commercial-scale cGMP batch of PH-762 drug substan | Oct 13, 2026 |
| ONDS | 8-K | bullish | 6/10 | Ondas Inc. announced the formation of Regna AI, a standalone private company initially wholly-owned by Ondas and powered | Oct 13, 2026 |
| CRVO | 8-K | bullish | 6/10 | CervoMed reported initial 12-week biomarker data from its Phase 2a trial of neflamapimod in nfvPPA, showing a mean reduc | Oct 13, 2026 |
| SABS | 8-K | bullish | 6/10 | SAB Biotherapeutics announced FDA Fast Track designation for SAB-142, its disease-modifying immunotherapy for Stage 3 ty | Oct 13, 2026 |
| MTVA | 8-K | neutral | 3/10 | MetaVia Inc. appointed Sarah Kaplan Browne, M.D. as Chief Medical Officer, effective October 12, 2026. Dr. Browne brings | Oct 13, 2026 |
| TRAX | 8-K | bullish | 7/10 | First Tracks Biotherapeutics announced positive top-line results from Cohort 1 of ANB033's Phase 1b gluten-challenge tri | Oct 13, 2026 |
| CRC | 8-K | neutral | 4/10 | CRC filed a preliminary Q3 2026 operational update via 8-K, disclosing estimated realized prices and a $134M net loss fr | Oct 13, 2026 |
| HSPOF | 8-K | bullish | 7/10 | Horizon Space Acquisition I Corp. (HSPOF) has entered into a definitive business combination agreement to merge with Arc | Oct 13, 2026 |
| ORBS | 8-K | bullish | 5/10 | Eightco Holdings received a Nasdaq compliance notice confirming its common stock regained compliance with the $1.00 mini | Oct 13, 2026 |
| ADBT | 8-K | neutral | 3/10 | Advasa Holdings announced five-year medium-term operating goals through fiscal 2031, targeting consolidated revenue of U | Oct 13, 2026 |
| NWTG | 8-K | bearish | 7/10 | Newton Golf Company received a final Staff Determination from Nasdaq on October 6, 2026, stating it has not demonstrated | Oct 13, 2026 |
| RWAY | 8-K | neutral | 3/10 | Runway Growth Finance Corp. issued a press release providing a Q3 2026 portfolio update, disclosing $8.5 million in foll | Oct 13, 2026 |
| IBIO | 8-K | bullish | 5/10 | iBio released preclinical body-composition data from an obese NHP study of IBIO-610, a first-in-class Activin E antibody | Oct 13, 2026 |
| ACCV | 8-K | bullish | 6/10 | Accelevation entered into a new $650 million senior secured credit agreement on October 9, 2026, replacing its prior fac | Oct 13, 2026 |
| SKYD | 8-K | mixed | 7/10 | Skydance Corporation (f/k/a Paramount Skydance Corporation) closed its acquisition of Warner Bros. Discovery, Inc. on Oc | Oct 13, 2026 |
| JNJ | 8-K | mixed | 6/10 | JNJ reported Q3 2026 adjusted EPS of $2.59, a -11.2% miss vs consensus of $2.92, and revenue of $25.4B vs $26.43B consen | Oct 13, 2026 |
| SUNS | 8-K | neutral | 4/10 | Sunrise Realty Trust announced a $20M stock repurchase program, contingent on the closing of its pending merger with Sou | Oct 13, 2026 |
| ONCY | 8-K | neutral | 3/10 | Oncolytics Biotech filed an 8-K announcing updates to its intellectual property portfolio for pelareorep. A new method-o | Oct 13, 2026 |
| CIFR | 8-K | mixed | 6/10 | Cipher Digital announced a proposed $850M private offering of 0.00% convertible senior notes due 2032 (with a $150M gree | Oct 13, 2026 |
| MIRM | 8-K | bullish | 7/10 | Mirum Pharmaceuticals announced positive topline results from the Phase 3 EXPAND study of LIVMARLI (maralixibat) in ultr | Oct 13, 2026 |
| PTON | 8-K | neutral | 2/10 | Peloton's Chief Accounting Officer Saqib Baig notified the company on October 8, 2026, of his resignation to pursue an e | Oct 13, 2026 |
| GIW | 8-K | neutral | 6/10 | GigCapital8 (GIW) entered into a definitive merger agreement to combine with Quantisimo Corp., a quantum and space techn | Oct 13, 2026 |
| ASST | 8-K | mixed | 5/10 | Strive, Inc. disclosed the purchase of 3,311 bitcoin at ~$84,500 each (~$280M total) during Oct 5-9, 2026, funded by a $ | Oct 13, 2026 |
| MEVO | 8-K | neutral | 2/10 | M Evo Global Acquisition Corp II appointed Richard Majlinder as an independent director and audit committee financial ex | Oct 13, 2026 |
| SLE | 8-K | neutral | 2/10 | Super League Enterprise disclosed the inaugural purchase of one Bitcoin for $83,041.40 as part of exploring Bitcoin as a | Oct 13, 2026 |
| CSX | 8-K | neutral | 3/10 | CSX announced the retirement of COO Mike Cory, effective immediately, with a transition period through May 2027. Two sen | Oct 13, 2026 |
| ASST | 8-K | mixed | 6/10 | Strive, Inc. filed two 8-Ks on consecutive days. The first (Oct 12) amends the SATA preferred stock certificate to estab | Oct 13, 2026 |
| CDT | 8-K | bearish | 7/10 | CDT Equity Inc. issued a $6,750,000 senior secured convertible note to J.J. Astor & Co., receiving $3,000,000 in the fir | Oct 13, 2026 |
| DCH | 8-K | neutral | 3/10 | Dauch Corp announced a structured CFO succession plan: Nathan Iles will join as SVP of Finance on Nov 2, 2026, and succe | Oct 13, 2026 |
| MSTR | 8-K | neutral | 4/10 | Strategy Inc disclosed weekly capital management updates: it purchased 250 BTC for $21.5 million (funded via $21.0M in M | Oct 13, 2026 |